ATA903974A - Verfahren zur herstellung eines diagnostischen mittels zur kontrolle der gerinnungsfahigkeit des blutes - Google Patents

Verfahren zur herstellung eines diagnostischen mittels zur kontrolle der gerinnungsfahigkeit des blutes

Info

Publication number
ATA903974A
ATA903974A AT903974A AT903974A ATA903974A AT A903974 A ATA903974 A AT A903974A AT 903974 A AT903974 A AT 903974A AT 903974 A AT903974 A AT 903974A AT A903974 A ATA903974 A AT A903974A
Authority
AT
Austria
Prior art keywords
coolatability
blood
preparing
control
diagnostic agent
Prior art date
Application number
AT903974A
Other languages
English (en)
Other versions
AT338981B (de
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19732356493 external-priority patent/DE2356493C3/de
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ATA903974A publication Critical patent/ATA903974A/de
Application granted granted Critical
Publication of AT338981B publication Critical patent/AT338981B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7452—Thrombomodulin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT903974A 1973-11-13 1974-11-12 Verfahren zur herstellung eines diagnostischen mittels zur kontrolle der gerinnungsfahigkeit des blutes AT338981B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732356493 DE2356493C3 (de) 1973-11-13 Verfahren zur Herstellung eines Thromboplastins und diagnostisches Mittel zur Kontrolle der Gerinnungsfähigkeit des Blutes

Publications (2)

Publication Number Publication Date
ATA903974A true ATA903974A (de) 1977-01-15
AT338981B AT338981B (de) 1977-09-26

Family

ID=5897898

Family Applications (1)

Application Number Title Priority Date Filing Date
AT903974A AT338981B (de) 1973-11-13 1974-11-12 Verfahren zur herstellung eines diagnostischen mittels zur kontrolle der gerinnungsfahigkeit des blutes

Country Status (20)

Country Link
US (1) US3983004A (de)
JP (1) JPS5843080B2 (de)
AT (1) AT338981B (de)
AU (1) AU497109B2 (de)
BE (1) BE822134A (de)
BR (1) BR7409498A (de)
CA (1) CA1043702A (de)
CH (1) CH611426A5 (de)
DK (1) DK138256C (de)
ES (1) ES431736A1 (de)
FI (1) FI327274A (de)
FR (1) FR2251002B1 (de)
GB (1) GB1490209A (de)
IE (1) IE40114B1 (de)
IT (1) IT1025596B (de)
LU (1) LU71264A1 (de)
NL (1) NL7414604A (de)
NO (1) NO744074L (de)
SE (1) SE7414232L (de)
ZA (1) ZA747287B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2525804B2 (de) * 1975-06-10 1980-04-03 Behringwerke Ag, 3550 Marburg Stabiler Clumping-Faktor, Verwendung desselben zum Nachweis von Fibrinogen- und Fibrinspaltprodukten und Herstellung desselben
US4116635A (en) * 1977-03-14 1978-09-26 Jaeger Mark A General purpose in vitro anticoagulant
DE2757992A1 (de) * 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
DE2836362A1 (de) * 1978-08-19 1980-03-06 Behringwerke Ag Diagnostisches mittel
US4276383A (en) * 1979-08-02 1981-06-30 The United States Of America As Represented By The Department Of Health, Education & Welfare Clot lysing timer
DE3150596A1 (de) * 1981-12-21 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von gewebsthromboplastin
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
NO852655L (no) * 1985-06-05 1986-12-08 Bio Data Corp Fremgangsmaate ved fremstilling av koaguleringsreagens for blodplasma i mikrokonsentrert tablettform.
US4755461A (en) * 1986-04-17 1988-07-05 Bio/Data Corporation Tableted blood plasma microconcentrated thromboplastin coagulation reagent
US5270451A (en) * 1988-11-23 1993-12-14 Baxter Diagnostics Inc. Extraction method for preparing thromboplastin reagents
US5281528A (en) * 1989-12-18 1994-01-25 Warner-Lambert Company Process for purified thromboplastin for ultra-pure thrombin preparation
US6261792B1 (en) 1990-12-07 2001-07-17 The Liposome Company, Inc. Lipid-dependent diagnostic assays
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
ATE313068T1 (de) 1998-10-07 2005-12-15 Trinity Biotech Mfg Ltd Thromboplastin-reagenzien und verfahren zur herstellung und anwendung derselben
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
WO2006088741A2 (en) * 2005-02-16 2006-08-24 The Board Of Trustees Of The University Of Illinois Procoagulants based on metal-chelating lipids
ATE505488T1 (de) * 2005-03-04 2011-04-15 Univ Illinois Modulator von coagulationskaskaden und fibrinolytischen kaskaden
WO2009046194A2 (en) * 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) * 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
US20210405072A1 (en) * 2018-09-25 2021-12-30 Sekisui Medical Co., Ltd. Method for measuring blood coagulation time

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2687980A (en) * 1948-09-15 1954-08-31 Ernest W Blanchard Thromboplastin product and method for preparing same
US2847347A (en) * 1954-05-27 1958-08-12 Ortho Pharmacentical Corp Preparation of improved thromboplastin
US3522148A (en) * 1965-08-13 1970-07-28 Dade Reagents Inc Stabilized thromboplastin preparation
BE787961A (fr) * 1971-08-24 1973-02-26 Behringwerke Ag Procede d'isolement d'une matiere thromboplastique et medicament contenant ladite matiere

Also Published As

Publication number Publication date
DK588174A (de) 1975-07-14
IE40114L (en) 1975-05-13
DE2356493B2 (de) 1976-09-16
AT338981B (de) 1977-09-26
US3983004A (en) 1976-09-28
ES431736A1 (es) 1977-05-16
FR2251002B1 (de) 1978-06-16
JPS5085393A (de) 1975-07-09
DK138256B (da) 1978-08-07
JPS5843080B2 (ja) 1983-09-24
IT1025596B (it) 1978-08-30
BE822134A (fr) 1975-05-13
ZA747287B (en) 1975-11-26
SE7414232L (de) 1975-05-14
DE2356493A1 (de) 1975-05-15
AU7522874A (en) 1976-05-13
DK138256C (da) 1979-01-22
IE40114B1 (en) 1979-03-14
NO744074L (de) 1975-06-09
FR2251002A1 (de) 1975-06-06
LU71264A1 (de) 1976-09-06
NL7414604A (nl) 1975-05-15
AU497109B2 (en) 1978-11-30
FI327274A (de) 1975-05-14
CH611426A5 (de) 1979-05-31
CA1043702A (en) 1978-12-05
BR7409498A (pt) 1976-05-25
GB1490209A (en) 1977-10-26

Similar Documents

Publication Publication Date Title
AT338981B (de) Verfahren zur herstellung eines diagnostischen mittels zur kontrolle der gerinnungsfahigkeit des blutes
DD132297A5 (de) Verfahren zur herstellung eines synergistischen pharmazeutischen mittels
AT318548B (de) Verfahren zur Herstellung eines Deshydratisierkatalysators
AT339290B (de) Verfahren zur herstellung neueralpha-athyl-benzhydrol-derivate
AT335616B (de) Verfahren zur herstellung eines mittels fur die spinalanasthesie
CH543878A (de) Verfahren zur Herstellung eines diagnostischen Mittels für medizinische Zwecke
AT334178B (de) Verfahren zur herstellung eines fettgemisches
AT334528B (de) Verfahren zur herstellung eines neuen komplexes des antibiotikums av290
AT331105B (de) Verfahren zur herstellung eines obersartigen konzentrats
AT317435B (de) Verfahren zur Herstellung eines antiseborrhoisch wirksamen Mittels
ATA885874A (de) Verfahren zur herstellung eines schwammartigen keramischen korpers
AT358737B (de) Verfahren zur herstellung eines antihaemophilen mittels
AT353543B (de) Verfahren zur herstellung eines nagetierbe- kaempfungsmittels
AT310939B (de) Verfahren zur Herstellung eines neuen lokalanästhetischen Mittels mit langer Wirkungsdauer
CH552377A (de) Verfahren zur herstellung eines diagnostischen mittels fuer medizinische zwecke.
AT305124B (de) Verfahren zur Herstellung eines Mittels zur Aromatisierung
ATA934075A (de) Verfahren zur herstellung des neuen 2-chlor -1,2,2- trifluorathyl - difluormethylathers
AT332538B (de) Verfahren zur herstellung eines 7beta-aminocephalosporins
AT328731B (de) Verfahren zur herstellung eines olefinischen nitrilcopolymers
AT344666B (de) Verfahren zur herstellung eines oxychlorierungskatalysators
AT305496B (de) Verfahren zur Herstellung eines blutstillenden Präparats
AT310767B (de) Verfahren zur Herstellung eines Diastereoisomerengemisches von Zearalanol
AT310768B (de) Verfahren zur Herstellung eines Diasteroisomerengemisches von Zearalanol
AT331402B (de) Verfahren zur herstellung eines neuen derivates der 6-trichloracetamidopenicillansaure
ATA598378A (de) Verfahren zur herstellung eines pharma- zeutischen blutstillenden mittels

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee